The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption

被引:0
作者
Wei, Shuhua [1 ]
Zhai, Zizhao [1 ]
Kong, Xi [1 ]
Wu, Chuanbin [1 ]
Zhu, Bing [2 ]
Zhao, Ziyu [1 ,3 ]
Zhang, Xuejuan [1 ]
机构
[1] Jinan Univ, Coll Pharm, Guangzhou 510006, Guangdong, Peoples R China
[2] Respirent Pharmaceut Co Ltd, Chongqing 40070, Peoples R China
[3] Jinan Univ, Coll Pharm, State Key Lab Bioact Mol & Druggabil Assessment, Guangzhou 511443, Peoples R China
关键词
Nasal drug delivery system; Nose-to-brain; Absorption efficiency; Central nervous system diseases; Efficiency-enhancing strategies; TO-BRAIN DELIVERY; HYALURONIC-ACID; EX-VIVO; NOSE; NANOPARTICLES; FORMULATION; SPRAY; TRANSPORT; CELLS; CORTICOSTEROIDS;
D O I
10.1016/j.ijpharm.2025.125584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nasal drug administration constitutes an efficient and non-invasive modality of drug delivery, and its distinctive physiological structure offers potentialities for treating a variety of diseases. To elevate the drug absorption and delivery efficiency, it is of paramount importance to delineate the transport routes and their enhancement mechanisms. Nevertheless, drug absorption pathways vary depending on the disease target, these variations present opportunities for targeted delivery and challenges for achieving precision. Hence, this review outlines the anatomical structure of the nasal cavity, and subsequently elaborates on the drug transport pathways within the nasal cavity and their influencing factors. Based on the distinct sites of drug action, diseases suitable for nasal drug administration are categorized into three types: systemic diseases, local nasal diseases, and central nervous system diseases. Grounded on multiple transport routes and their influencing factors, this review proposes strategies like optimizing formulation viscosity, using penetration enhancers, adding mucosal adhesives and improving delivery device, offering insights into future advancements in nasal drug delivery systems.
引用
收藏
页数:15
相关论文
共 159 条
[1]   Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative [J].
Akita, Tomomi ;
Oda, Yusuke ;
Kimura, Ryosuke ;
Nagai, Mio ;
Tezuka, Ayano ;
Shimamura, Mizuki ;
Washizu, Kaho ;
Oka, Jun-Ichiro ;
Yamashita, Chikamasa .
JOURNAL OF CONTROLLED RELEASE, 2022, 351 :573-580
[2]   Novel drug-delivery systems for patients with chronic rhinosinusitis [J].
Albu, Silviu .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 :125-132
[3]   N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why [J].
Aldini, Giancarlo ;
Altomare, Alessandra ;
Baron, Giovanna ;
Vistoli, Giulio ;
Carini, Marina ;
Borsani, Luisa ;
Sergio, Francesco .
FREE RADICAL RESEARCH, 2018, 52 (07) :751-762
[4]  
Alexander HE, 1937, J EXP MED, V65, P317, DOI 10.1084/jem.65.2.303
[5]   IN VIVO ASSESSMENT OF GROWTH-INHIBITORY AND MUCIN-DEPLETING EFFECTS OF BROMELAIN AND N-ACETYLCYSTEINE IN PERITONEAL CARCINOMATOSIS MODELS [J].
Amini, A. ;
Masoumi-Moghaddam, S. ;
Morris, D. L. .
ANNALS OF ONCOLOGY, 2015, 26 :28-28
[6]   A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules [J].
Aspelund, Aleksanteri ;
Antila, Salli ;
Proulx, Steven T. ;
Karlsen, Tine Veronica ;
Karaman, Sinem ;
Detmar, Michael ;
Wiig, Helge ;
Alitalo, Kari .
JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (07) :991-999
[7]   Physicochemical and physiological considerations for efficient nose-to-brain targeting [J].
Bahadur, Shiv ;
Pathak, Kamla .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (01) :19-31
[8]   Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance [J].
Berger, William E. ;
Godfrey, James W. ;
Slater, Anna L. .
EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (06) :689-701
[9]   Thiomers:: potential excipients for non-invasive peptide delivery systems [J].
Bernkop-Schnürch, A ;
Krauland, AH ;
Leitner, VM ;
Palmberger, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) :253-263
[10]   Thiolated polymers:: synthesis and in vitro evaluation of polymer-cysteamine conjugates [J].
Bernkop-Schnürch, A ;
Clausen, AE ;
Hnatyszyn, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 226 (1-2) :185-194